A regenerative medicine company focused on repairing damaged organs with engineered biomaterials and immunomodulatory stem cell factors. We have developed a patented/novel "off-the-shelf" absorbable implant to regenerate damaged tissue/organs within the body to address a > $200B global regenerative medicine market. Our first commercial therapeutic application for the implant is to regenerate a damaged esophagus to treat esophageal cancer and other sever ailments of the esophagus (i.e., Advanced Barrett's, GERD, pediatric atresia, physical trauma, etc.)